177Lu-R11228
/ Radionetics Oncology
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 21, 2025
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
(clinicaltrials.gov)
- P1 | N=62 | Recruiting | Sponsor: Radionetics Oncology | Not yet recruiting ➔ Recruiting
Enrollment open • Breast Cancer • HER2 Negative Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor
August 18, 2025
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
(clinicaltrials.gov)
- P1 | N=62 | Not yet recruiting | Sponsor: Radionetics Oncology
New P1 trial • Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1